Synairgen’s inhaled COVID-19 treatment included in US trial by Lucy Parsons | Feb 10, 2021 | News | 0 Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID) Read More
Synairgen begins large-scale trial of inhaled COVID-19 treatment by Lucy Parsons | Jan 13, 2021 | News | 0 First patient in global trial dosed in the UK Read More
Synairgen’s SNG001 shows strong promise in COVID-19 trial by Selina McKee | Jul 20, 2020 | News | 0 The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover versus placebo Read More
AZ pulls plug on Phase II asthma trial by Selina McKee | Oct 13, 2016 | News | 0 AstraZeneca has called time on a mid-stage trial assessing an experimental inhaled interferon beta licensed from Southampton, UK-based group Synairgen. Read More